Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $189,504 - $260,505
-2,100 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$99.61 - $142.12 $189,259 - $270,028
-1,900 Reduced 47.5%
2,100 $278,000
Q3 2019

Nov 12, 2019

SELL
$90.37 - $122.49 $90,370 - $122,490
-1,000 Reduced 20.0%
4,000 $361,000
Q2 2018

Aug 03, 2018

BUY
$37.84 - $69.96 $18,920 - $34,980
500 Added 11.11%
5,000 $299,000
Q3 2017

Nov 03, 2017

BUY
$37.05 - $47.12 $166,725 - $212,040
4,500
4,500 $212,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pekin Hardy Strauss, Inc. Portfolio

Follow Pekin Hardy Strauss, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.